Evidence map›Paper›PMID 36543519›Full record

Observational studyHeart (British Cardiac Society)2023

Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction.

Fusako Sera, Tomohito Ohtani, Shunsuke Tamaki, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Daisaku Nakatani, Takahisa Yamada, Yoshio Yasumura and 4 more

Open access · greenAbstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Heart (British Cardiac Society), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Fusako SeraDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-9260-6901
Tomohito OhtaniDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan ohtani@cardiology.med.osaka-u.ac.jp.
Shunsuke TamakiDivision of Cardiology, Osaka General Medical Center, Osaka, Japan.
Masamichi YanoDivision of Cardiology, Osaka Rosai Hospital, Sakai, Japan.
Takaharu HayashiDepartment of Cardiovascular Medicine, Osaka Police Hospital, Osaka, Japan.
Akito NakagawaDivision of Cardiovascular Medicine, Amagasaki Chuo Hospital, Amagasaki, Japan.ORCID 0000-0001-8276-1505
Yusuke NakagawaDivision of Cardiology, Kawanishi City Hospital, Kawanishi, Japan.
Daisaku NakataniDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Takahisa YamadaDivision of Cardiology, Osaka General Medical Center, Osaka, Japan.
Yoshio YasumuraDivision of Cardiovascular Medicine, Amagasaki Chuo Hospital, Amagasaki, Japan.
Shungo HikosoDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0003-2284-1970
Keiko Yamauchi-TakiharaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Yasushi SakataDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Osaka Cardiovascular Conference (OCVC)-Heart Failure Investigators
The University of Osaka · JPOsaka Prefectural Medical Center · JPKishiwada City Hospital · JPOsaka Police Hospital · JPOsaka Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHeart failure with preserved ejection fraction (HFpEF) is often complicated by pulmonary hypertension (PH), which is mainly characterised by postcapillary PH and occasionally accompanied by a precapillary component of PH. Haemodynamic changes in worsening heart failure (HF) can modify the characteristics of PH. However, the clinical features of PH after HF treatment in HFpEF remain unclear. We investigated the prevalence and clinical significance of the precapillary component of PH after HF treatment in HFpEF, using data from the Prospective Multicentre Observational Study of Patients with HFpEF (PURSUIT-HFpEF).

methodsFrom the PURSUIT-HFpEF registry, 219 patients hospitalised with acute HF who underwent right heart catheterisation after initial HF treatment were divided into four groups according to the 2015 and 2018 PH definitions: non-PH, isolated postcapillary pulmonary hypertension (Ipc-PH), precapillary PH and combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). The latter two were combined as PH with the precapillary component.

resultsUsing the 2015 definition, we found that the prevalence of PH after HF treatment was 27% (Ipc-PH: 20%, precapillary PH: 3%, Cpc-PH: 4%). Applying the 2018 definition resulted in a doubled frequency of precapillary PH (6%). PH with a precapillary component according to the 2015 definition was associated with poor clinical outcomes and characterised by small left ventricular dimension and high early diastolic mitral inflow velocity/early diastolic mitral annular tissue velocity.

conclusionAfter initial HF treatment, 7% of hospitalised patients with HFpEF had precapillary component of PH according to the 2015 definition. Echocardiographic parameters of the left ventricle can contribute to the risk stratification of patients with HFpEF with a precapillary component of PH.

Indexed as

Heart FailureHypertension, PulmonaryEchocardiographyHumansProspective StudiesStroke Volumeechocardiographyhaemodynamicsheart failurehypertension, pulmonary

Identifiers

PMID36543519
OpenAlexW4312061327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.